The American Dental Association (ADA) refers to the disorder related to bone necrosis of the jaw due to taking bisphosphonates and other antiresorptive therapy as:

Question

Quizplus · Accepted Answer

Bone necrosis of the jaw, due to bisphosphonate therapy, is referred to in a variety of different terms. The American Association of Oral and Maxillofacial Surgeons (AAOMS) refers to the disorder as bisphosphonate-related osteonecrosis of the jaw (BRONJ), while the most recent November 2011 guidelines from the American Dental Association (ADA) Council on Scientific Affairs adopted the term antiresorptive agent-induced ONJ (ARONJ). Other terminology used throughout the literature, which refers to osteonecrosis of the jaw by professional associations includes: osteochemonecrosis, bisphosphonate-induced osteonecrosis of the jaw (BIONJ), bisphosphonate-associated osteonecrosis of the jaw (BONJ), bisphosphonate-associated osteonecrosis (BON), and aseptic osteonecrosis (AON).

The American Dental Association (ADA) Refers to the Disorder Related